Clinical Trial Update: A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of CU-20101 Botulinum toxin Type A for injection in treating glabellar frown lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED